| Date Filed | Type | Description |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2023 |
4
| Simpson Jennifer K. (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 16,253 options to buy
@ $26, valued at
$422.6k
|
|
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2022 |
4/A
| Simpson Jennifer K. (Director) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 50,000 options to buy
@ $0.45, valued at
$22.5k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2021 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 19,125 options to buy
@ $2.26, valued at
$43.2k
|
|
| 08/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/01/2021 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 170,000 options to buy
@ $4.09, valued at
$695.3k
|
|
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2020 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 1,000 shares
@ $2.7371, valued at
$2.7k
|
|
| 09/01/2020 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 2,424 shares
@ $0
Bought 2,424 warrants
@ $4.54, valued at
$11k
|
|
| 07/17/2020 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Granted 212,048 options to buy
@ $9.99, valued at
$2.1M
|
|
| 07/17/2020 |
3
| Simpson Jennifer K. (President and CEO) has filed a Form 3 on Sun BioPharma, Inc. |
| 05/08/2020 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Granted 10,310 shares
@ $0
Converted 14,700 shares
@ $0
Converted 147 convertible preferred
@ $0 |
|
| 01/07/2020 |
4
| Simpson Jennifer K. (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $59.795, valued at
$598k
|
|
| 10/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2019 |
3
| Simpson Jennifer K. (Director) has filed a Form 3 on EAGLE PHARMACEUTICALS, INC. |
| 07/26/2019 |
4
| Simpson Jennifer K. (President and CEO) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 147 convertible preferred
@ $1000, valued at
$147k
Bought 2,450,000 warrants
@ $0 |
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/23/2018 |
4
| Simpson Jennifer K. (President & CEO) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 7,399 shares
@ $1.75, valued at
$12.9k
|
|
| 08/02/2018 |
4
| Simpson Jennifer K. (President & CEO) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Bought 100 shares
@ $2.55, valued at
$255 |
|
| 06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2015 |
4
| Simpson Jennifer K. (President & CEO) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Granted 201,375 shares
@ $0
Granted 95,125 options to buy
@ $1.19, valued at
$113.2k
|
|
| 11/18/2013 |
4
| Simpson Jennifer K. (Interim Co-CEO&Pres.EVP Market) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Granted 185,997 options to buy
@ $0.3, valued at
$55.8k
|
|
| 03/13/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/04/2012 |
4
| Simpson Jennifer K. (Exec. VP, Global Marketing) has filed a Form 4 on DELCATH SYSTEMS INC|
Txns:
| Bought 3,000 shares
@ $1.49, valued at
$4.5k
|
|
| 03/26/2012 |
4
| Simpson Jennifer K. (Exec. VP, Global Marketing) has filed a Form 4 on DELCATH SYSTEMS INC|
Txns:
| Granted 7,500 shares
@ $0
Granted 60,000 options to buy
@ $3.17, valued at
$190.2k
|
|